References
- Alaupovic P, Curry M D, McConathy W J. Quantitative determination of human plasma apolipoproteins by electroimmunoassays. International conference on atherosclerosis, L A Carlson, R Paoletti, C R Sirtori, G Weber. Raven Press, NY 1978; 109–15
- Albers J J. The determination of apoproteins and their diagnostic value in clincal chemistry. XI International Congress of Clinical Chemistry, E Kaiser, F Gabl, M M Müller, M Bayer. Walter de Gruyter & Co., Berlin, New York 1982; 221–8
- Kostner G. Apolipoproteins and lipoproteins of human plasma: Significance in health and in disease. Adv Lipid Res 1983; 20: 1–43
- Naito H K. Reliability of lipid, lipoprotein and apolipoprotein measurements. Clin Chem 1988; 34: B84–B94
- Avogado P, Bittolo B, Cassolato G, Quinci G B. Are apolipoproteins better discriminators than lipids for atherosclerosis. Lancet 1979; i: 901–3
- Levinson S S. Fundamental problems with assays of apolipoprotein A-I. Clin Chem 1990; 36: 700–1
- Brown S A, Boerwinkle E, Kashanian F K, Swanson N, Patsch W. Variation in concentrations of lipids, lipoprotein lipids, and apolipoproteins A-I and B in plasma from healthy women. Clin Chem 1990; 36: 207–10
- Henderson L O, Powell M K, Smith S J, Hannon W H, Cooper G R, Marcovina S M. Impact of protein measurements on standardization of assays of apolipoproteins A-I and B. Clin Chem 1990; 36: 1911–7
- Marcovina S M, Albers J J, Dati F, Ledue T B, Ritchie R F. International Federation of Clinical Chemistry standardization project for measurements of apolipoprotein A-I and B. Clin Chem 1991; 37: 1676–82
- Koren E, Puchois P, Alaupovic P, Fesmire J, Kandoussi A, Fruchart J-C. Quantification of two different types of apolipoprotein A-I containing lipoprotein particles in plasma by enzyme-linked differential-antibody immunosorbent assay. Clin Chem 1987; 33: 38–43
- Miller G J, Miller N E. Plasma-high-densitylipoprotein concentration and development of ischaemic heart-disease. Lancet 1975; i: 16–9
- Castelli W P, Doyle J T, Gordon T, Hames C G, Hjortland M C, Hulley S B, Kagan A, Zugel W J. HDL cholesterol and other lipids in coronary heart disease. Circulation 1977; 55: 767–72
- Williams P, Robinson D, Bailey A. High-density lipoprotein and coronary risk factors in normal men. Lancet 1979; i: 72–5
- Warnick G R, Knopp R H, Fitzpatrick V, Branson L. Estimating low-density lipoprotein cholesterol by the Friedwald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem 1990; 36: 15–9
- Penttilä I M. How to measure cholesterol in lipoprotein fractions by direct methods adequately. Scand J Clin Lab Invest 1988; 48(Suppl. 190)56–8
- Freidewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparation ultracentrifuge. Clin Chem 1972; 18: 499–502
- Carlson K. Lipoprotein fractiönation. J Clin Path 1973; 26(Suppl.)32–7
- Kostner G M. Current methods for apolipoprotein evaluation in normal and dislipoproteinaemic plasma. La Ric Clin Lab 1982; 12: 155–161
- Lippi U, Bertolini D, Graziani M S. Apolipoprotein A-I concentrations in serum: a pragmatic approach to assessing risk of heart disease. Clin Chem 1990; 36: 701
- Penttilä I M, Voutilainen E, Laitinen P, Juutilainen P. Comparison of different analytical and precipitation methods for direct estimation of serum high-density lipoprotein cholesterol. Scand J Clin Lab Invest 1981; 41: 353–60
- Jessen R H, Dass C J, Eckfeldt J H. Do enzymatic analyses of serum triglycerides really need blanking for free glycerol. Clin Chem 1990; 36: 1372–5
- Riepponen P, Marniemi J, Rautoja T. Immunoturbidimetric determination of apolipoproteins A-I and B in serum. Scand J Clin Lab Invest 1987; 47: 739–44
- Grauholt A-M, Grande P, Hørby-Petersen J, Jensen J, Rostgaard M, Meinertz H. High-density lipoprotein cholesterol assay by magnesium dextransulphate precipitation. Scand J Clin Lab Invest 1986; 46: 715–21
- Schriewer H, Emke F, Funke H, Schulte H, Assmann G. HDL apolipoprotein A-I and HDL apolipoprotein A-II concentrations in male company employees in Westphalia aged 40 years or older. J Clin Chem Clin Biochem 1986; 24: 627–35
- Warnick G R, Cheung M C, Albers J J. Comparison of current methods for high-density lipoprotein cholesterol quantitation. Clin Chem 1979; 25: 596–604
- Wiebe D A, Smith S J. Six methods for isolating high-density lipoprotein compared, with use of the reference method for quantifying cholesterol in serum. Clin Chem 1985; 31: 746–50
- Penttilä I, Väisänen S, Puhakainen E. The apolipoprotein composition of supernatants commonly used for the determination of HDL-and LDL-cholesterol. Biochimica Clinica 1989; 13: 233
- Pilger E, Pristautz H, Pfeiffer K P, Kostner G. Risk factors for peripheral atherosclerosis. Retrospective evaluation by stepwise discriminant analysis. Arteriosclerosis 1983; 3: 57–63
- Puchois P, Luley C, Alapouvic P. Comparison of four procedures for separating apolipoprotein A-and apolipoprotein B-containing lipoproteins in plasma. Clin Chem 1987; 33: 1597–602
- Riesen W F, Mordasini R, Salzman C, Theler A, Gurtner H P. Apolipoproteins and lipids as discriminators of severity of coronary heart disease. Atherosclerosis 1980; 37: 157–62
- Tyroler H A. Cholesterol and cardiovascular disease An overview of Lipid Research Clinics (LRC) epidemiologic studies as background for the LRC coronary primary prevention trial. Am J Cardiol 1984; 54: 14C–19C
- Assmann G, Jabs H-U, Kohnert U, Nolte W, Schriewer H. LDL-cholesterol determination in blood serum following precipitation with polyvinylsulphate. Clin Chim Acta 1984; 140: 77–83
- Mulder K, van Leeuwen C, Schouten J A, van Gent C M, Snel M T, Lahey J, van der Voort H A. An evaluation of three commercial methods for the determation of LDL-cholesterol. Clin Chim Acta 1984; 143: 29–35
- Hoffmann G E, Hiefinger R, Weiss L, Poppe W. Five methods for measuring low-density lipoprotein cholesterol concentration in scrum compared. Clin Chem 1985; 31: 1729–30
- Gibson J C, Rubinstein A, Brown W V. Precipitation of apo E-containing lipoproteins by precipitation reagents of apolipoprotein B. Clin Chem 1984; 30: 1784–8
- Ga-Estrada M G, Rodriguez Ferrer C R, Astarloa A I, Lahera E M. Use of serum cholesterol/triglyceride ratio to discern for which individuals the Friedewald formula can be used confidently. ClinChem 1990; 36: 1673–5
- Schriewer H, Nolle W, Robenak H, Assmann G. Apolipoprotein B determination in the dissolved precipitate obtained after precipitation of LDL with polyvinylsulphate: An alternative method for the determination of LDL apolipoprotein B without using ultracentrifugation. J Clin Chem Clin Biochem 1986; 24: 347–52
- Phillips M L, Schumaker V N. Conformation of apolipoprotein B after lipid extraction of low density lipoprotein attached to an electron microscope grid. J Lipid Res 1989; 30: 415–22